#anthropic-ipo — Wealth & Means

Episodes tagged #anthropic-ipo on Wealth & Means.

More Control, or Just a Better Interface? — 2026-07-25
There's a difference between the part of a system you interact with and the part that actually governs it. This week: infrastructure becoming programmable in ways you won't notice until the interface changes, a Fed decision and mega-cap earnings colliding on the same afternoon, the insurance that quietly holds everything up, two thinkers arguing about who designs the environments children grow up inside, and a physicist who refused to improve a perfectly good propeller.
What's Actually Holding This Up — 2026-07-18
Trade corridors nobody's signed yet, a synthetic cell nobody's sure is alive, two SPACs betting on decades that haven't happened, a Fed chair promising to end a five-year inflation story, two trillion-dollar earnings nights landing on the same Wednesday, a resume trying to survive a machine before it reaches a human, and a chemist who got rich finding value in what everyone else called lab residue.

#anthropic-ipo — Wealth & Means

Episodes tagged #anthropic-ipo on Wealth & Means.

More Control, or Just a Better Interface? — 2026-07-25
There's a difference between the part of a system you interact with and the part that actually governs it. This week: infrastructure becoming programmable in ways you won't notice until the interface changes, a Fed decision and mega-cap earnings colliding on the same afternoon, the insurance that quietly holds everything up, two thinkers arguing about who designs the environments children grow up inside, and a physicist who refused to improve a perfectly good propeller.
What's Actually Holding This Up — 2026-07-18
Trade corridors nobody's signed yet, a synthetic cell nobody's sure is alive, two SPACs betting on decades that haven't happened, a Fed chair promising to end a five-year inflation story, two trillion-dollar earnings nights landing on the same Wednesday, a resume trying to survive a machine before it reaches a human, and a chemist who got rich finding value in what everyone else called lab residue.